The US Food and Drug Administration (FDA) posted a Safety Communication informing healthcare practitioners and patients about reports of squamous cell carcinoma (SCC) and various lymphomas (not including BIA-ALCL) detected in the capsule surrounding breast implants. These reports highlight a very rare occurrence of malignancy. We believe that developments such as this deserve attention so that you, your staff, and your patients may stay informed.
View Update
Safety Communication on Breast Implant Associated Squamous Cell Carcinoma (BIA-SCC)
This statement was published by the US Food and Drug Administration (FDA) and is provided here for informational purposes only. ISAPS was not involved in its authorship or approval and does not endorse or take responsibility for its content. Members should exercise their own professional judgment and refer to official guidelines and regulations in their respective countries.